Abstract
Introduction
Chronic kidney disease (CKD) is a devastating disease and universally it becomes more predominant 1 .Assessment of the kidney function by measurement of glomerular filtration rate in routine clinical practice is a part of follow up of kidney diseases. Though, the measurement of GFR by using exogenous markers clearance are accurate, they are unsuitable due to their inconvenience, high cost, laborious and cumbersome 2 .Under this situation, we are in a position to estimating the GFR by using various calculations. Conventionally, number of equations have been considered for GFR estimation. Among these equations, the Modification of Diet in Renal Disease (MDRD) 3 , Cockcroft-Gault 4 and Chronic Kidney Disease Epidemiology collaboration (CKD-EPI) 5 have been accepted for creatinine based equations to estimate the GFR. However, there are a number of disadvantages in using serum creatinine itself as a filtration marker 6, 7 . Hence, identifying an alternative filtration marker is vital for accurate, reproducible and unbiased estimation of GFR. Serum cystatin C is a one such marker produced from all nucleated cells at a constant rate and freely filtered by glomerulus 8 . The cystatin C has been completely metabolised and 99% reabsorbed in the peroximal tubules 9, 10 . Because of these key factors, serum cystatin C has been proposed and proved as a superior marker for predicting GFR than serum creatinine 11 . Even though its superiority over serum creatinine is well known, its role in predicting glomerular filtration rate and validation of cystatin C based formulae are still conflicting [12] [13] [14] [15] [16] . Hence, the present study aimed to determine the efficiency of cystatin C and its formulae for estimating eGFR and creatinine based formulae compare with measured GFR (Tc-99m-DTPA) in all stages of Indian CKD patients.
Materials and Methods

Participants
Totally 201 Indian participants greater than 18 years, with CKD at the private nephrology outpatient clinic were consecutively enrolled in the study. All participants in this study signed the informed consent. The participants with severe heart failure, acute renal failure, pleural or abdominal effusion, serious edema or malnutrition, skeletal muscle atrophy, amputation, ketoacidosis were excluded. Patients who were taking trimethoprim or cimetidine or ACEI/ARB and those who had recently received glucocorticoid andhemodialysis therapy were also excluded. The patients are classified in to five groups based on the GFR levels namely group 1-End stage kidney disease (<15 ml/min/1.73m 2 ; N= 32), Group 2-Severe stage kidney disease (16- 
Measurement and Estimation of GFR GFR Measurement using
99m Tc-DTPA Renography The patients are made to lie down on a bed in the supine position. 99mTc-DTPA was injected through an indwelling butterfly needle in to anticubital vein and followed by infusion of 20 ml of normal saline. Frames of 128 x 128 matrix were recorded with an online-computer, initially at one second for one minute and then at 10 seconds for 20 minutes. Region of interest (ROI) over each kidney assigned manually on the frame was added from 1 to 3 minutes following injection. The semi lunar background ROI around each kidney was defined and was modified for the inferior ROI's in the original gates. The background corrected time-activity curve was generated and the renal update of individual kidney for one minute period from 2 to 3 minutes after the injection was calculated. The GFR was automatically estimated by a commercially available computer programme (E. CAM, Siemens, USA) according to the Gate's 17 algorithm.
Creatinine and Cystatin C assay All creatinine measurements were performed in the same laboratory. Blood samples were obtained simultaneously with the GFR measurement. Serum creatinine was measured by Jaffe's method using auto analyser (A 15, Bio systems, USA). Serum cystatin C was measured by particle enhanced nephelometricimmuno assay (PENIA) (Dade Behring, Germany).
Creatinine Based Estimation of GFR
The two formulae studied to predict GFR from serum creatinine were the one proposed by Cockcroft and Gault 4 . GFR CG = [(140-age) × weight (kg)] / 72 × S.Cr (mg/dl) (for women, multiply with 0.8) and the one simplified from the MDRD formula 18 . GFR MDRD (78) x (1/cystatin C)] + 4 GFR was measured using 99mTc-DTPA and all formulae were compared with it. In this study isotope GFR was considered gold standard and all calculated formulae were compared with it, in the absence of inulin clearance. CKD EPI 
Results
Baseline characteristics
A total of 201 CKD patients (Male: 149; Female: 52) were enrolled in the present study and they were categorised in to five groups based on GFR and other baseline characteristicsaccording to the CKD stages are summarized in Table 1 . 
Performance of Various formulae in End Stage Chronic Kidney Disease
The measured GFR using 99m-DTPA renal scan had compared with the serum cystatin C with its formulae and Creatinine with its formulae in the end stage chronic kidney disease patients. The relationship was checked by doing correlation analyses with the above said parameters. Among serum creatinine and cystatin C compared with the measured GFR, the cystatin C had better negative correlation (r = -0.5162; p=0.0025) than creatinine (r = -0.3953; p=0.0251) with measured GFR. Similarly, the various formulae based on both cystatin C and Creatinine used for estimation of GFR were compared with measured GFR (Fig.1) .
Among the various formulae, CKD EPI cystatin C showed significant correlation (r = 0.8180; P<0.0001) with measured GFR than MDRD (r = 0.3485; P =0.0506), LeBricon (r = 0.2137; P =0.0958), Hoek (r = 0.5180; P =0.0024), CKD EPI Creatinine (r = 0.3601; P = 0.0429) and CKD EPI Creatinine-Cystatin C (r = 0.4458; P =0.0106).The ROC analysis of various formulae had been compared and the CKD EPI Cystatin C showed higher AUC (0.966) and higher sensitivity (92.3 %) & specificity (100 %) than other formulae ( Table 2) .
Performance of Various formulae in Severe Stage Chronic Kidney Disease
The measured GFR using 99m-DTPA renal scan had compared with the serum cystatin C with its formulae and Creatinine with its formulae in the severe stage chronic kidney disease patients. The relationship was checked by doing correlation analyses with the above said parameters. Among serum creatinine and cystatin C compared with the measured GFR, the cystatin C had better negative correlation (r=-0.5489; p≤0.0001) than creatinine (r = -0.2389; p=0.0710) with measured GFR. Similarly, the various formulae based on both cystatin C and Creatinine used for estimation of GFR were compared with measured GFR (Fig.2) .
Among the various formulae, CKD EPI cystatin C showed significant correlation (r=0.9990; p<0.0001) with measured GFR than MDRD (r = 0.3365; p=0.0098), LeBricon (r=0.7942; p< 0.0001), Hoek (r= 0.6708; p=0.0001), CKD EPI Creatinine (r = 0.3445; p= 0.0081) and CKD EPI Creatinine-Cystatin C (r=0.3976; p=0.0020).The ROC analysis of various formulae had been compared and the CKD EPI CystatinC showed higher AUC (0.907) and higher sensitivity (98.1%) than other formulae ( Table 2) .
Performance of Various formulae in Moderate Stage Chronic Kidney Disease
The measured GFR using 99m-DTPA renal scan had compared with the serum cystatin C with its formulae and Creatinine with its formulae in the moderate stage chronic kidney disease patients. The relationship was checked by doing correlation analyses with the above said parameters. Among serum creatinine and cystatin C compared with the measured GFR, the cystatin C had better negative correlation (r = -0.7241; p<0.0001) and creatinine did not significantly correlate (r = -0.1369; p=0.2583) with measured GFR. Similarly, the various formulae based on both cystatin C and Creatinine used for estimation of GFR were compared with measured GFR (Fig.3) . Among the various formulae, CKD EPI cystatin C showed significant correlation (r= 0.8040; p<0.0001) with measured GFR than LeBricon (r=0.6546; p<0.0001) and CKD EPI Creatinine (r=0.2720; p=0.0228). Moreover, Hoek (r=0.4546; p=0.7385), MDRD (r=0.2562; p=0.3230) and CKD EPI CreatinineCystatin C (r=0.1482; p=0.2208) did not significantly correlate with the measured GFR. The ROC analysis of various formulae had been compared and the CKD EPI Cystatin C showed higher AUC (0.833) and higher sensitivity (93.3 %) &specificity (100 %) than other formulae (Table 2) . 
Performance of Various formulae in MildStage Chronic Kidney Disease
The measured GFR using 99m-DTPA renal scan had compared with the serum cystatin C with its formulae and Creatinine with its formulae in the mild stage chronic kidney disease patients. The relationship was checked by doing correlation analyses with the above said parameters. Among serum creatinine and cystatin C compared with the measured GFR, the cystatin C had better negative correlation (r=-0.7933; p<0.0001) than creatinine (r = 0.02365; p=0.9168) with measured GFR. Similarly, the various formulae based on both cystatin C and Creatinine used for estimation of GFR were compared with measured GFR (Fig.4) (r= 0.1716; p=0.4451) did not significantly correlate with measured GFR. The ROC analysis of various formulae had been compared and the CKD EPI Cystatin C showed higher AUC (0.974) and higher sensitivity (96.8 %) and specificity (100%) than other formulae (Table 2) .
Discussion
Estimation of the glomerularfiltration rate (GFR) is themost important step in the diagnosis of chronic kidney disease(CKD), and significant research has been directed towarddeveloping the most accurate, convenient, and reproducibleequation. 3 equationshave been considered the most acceptable creatinine-basedequations for estimating GFR.However, there are a number of disadvantages in using serumcreatinine itself as afiltration marker 6, 7 . Therefore, identifying a new endogenous filtration marker is necessary for theaccurate and convenient estimation of GFR. Since cystatin C is less affected by muscle mass and diet than is creatinine [24] [25] [26] it has been widely anticipated thatcystatin C wouldprovide a more accurate estimate of GFR than would creatinine. The advantage of the cystatin C-based equation over the creatinine-based equation is that it is less subject to the effects of age, sex, and race.
Accurate estimation of GFR is important for interpreting the symptoms and laboratory abnormalities that may specify the kidney disease; for therapeutic dosing; and for detecting and managing chronic kidney disease and assessing the prognosis. A reduction in GFR to less than 60 ml/min/1.73m 2 for 3 months or longer is a diagnostic criterion for chronic kidney disease and is associated with an increased risk of adverse outcomes, including death [20] [21] [22] [23] . Bias with the new, combined creatininecystatin C equation and with the average of the new cystatin C equation and the creatinine equation was similar to that with the individual creatinine and cystatin C equations, but they had greater precision and accuracy and resulted in more accurate classification of measured GFR as less than 60 ml/ min/1.73m 2 the threshold for the diagnosis of chronic kidney disease.
The present study compared the sensitivity and specificity of new formulae with other existing equations in 201 participants with normal to advanced stages of kidney diseases. The vital conclusion of the study was that CKD-EPI CystatinC formula had better diagnostic value towards higher sensitivity and specificity in the entire participants including normal to advanced kidney disease participants.
